Schizophrenia Medication Under-Prescribed Despite Efficacy for Severe Cases

A study reveals that a specific active ingredient for schizophrenia, effective for patients unresponsive to standard treatments, is being prescribed too infrequently, despite its potential to help one-third of patients.